Announcing a new article publication for Cardiovascular Innovations and Applications journal. Risk prediction models are an important part of assessing operative mortality and postoperative complication rates in current cardiac surgery practice.
Mirum expands rare disease portfolio with digestive disorder drugs – Pharmaceutical Technology
Mirum Therapeutics acquired two bile disorder drug products from Travere Therapeutics. Credit: peakSTOCK via Getty Images. California-based biotech Mirum Therapeutics has announced the completion of
September 6, 2023